By Professor David Lawson Morris

Journal articles

Morris DL; Jourdan JL; Pourgholami MH, 2001, 'Pilot study of albendazole in patients with advanced malignancy: Effect on serum tumor markers/high incidence of neutropenia', Oncology, 61, pp. 42 - 46, http://dx.doi.org/10.1159/000055351

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1α,25-dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2', ANZ Journal of Surgery, 71, pp. 414 - 417, http://dx.doi.org/10.1046/j.1440-1622.2001.02147.x

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2', Australian and New Zealand Journal of Surgery, pp. 414 - 417

Finlay I; Stewart GJ; Akhter J; Morris DL, 2001, 'A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers', Journal of Gastroenterology and Hepatology, 16, pp. 333 - 337

Sidhu S; Magarey CJ; King J; Schwartz P; Morris DL, 2001, 'Adjuvant cimetidine in breast carcinoma: A prospective randomised control trial', Asian Journal of Surgery, pp. 161 - 163

Teoh W; Haghighi K; Morris DL, 2001, 'Aggressive multimodality treatment for primary malignant peritoneal mesothelioma', Australian and New Zealand Journal of Surgery, pp. 683 - 685

Finlay I; Stewart GJ; Shirley P; Woolfe S; Pourgholami MH; Morris DL, 2001, 'Hepatic arterial and intravenous administration of 1,25 dihydroxyvitamin D3 - evidence of a clinically significant hepatic first-pass effect', Cancer Chemotherapy and Pharmacology, pp. 209 - 214

Finlay I; Stewart GJ; Akhter J; Morris DL, 2001, 'Hepatocellular Carcinoma Treatment and Recurrence Marker. A Phase one study of the hepatic arterial administration of 1,25 dihydroxyvitamin D3 for liver cancers', Journal of Gastroenterology and Hepatology, 16, pp. 333 - 337

Pourgholami MH; Woon LA; Almajd R; Akhter J; Bowrey P; Morris DL, 2001, 'In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole', Cancer Letters, 165, pp. 43 - 49

Nye E; Butler P; Clingan P; Morris DL, 2001, 'Lipiodol avid liver metastases from adrenocortical carcinoma; Prospects for therapy?', Anticancer Research, 21, pp. 1445 - 1448

Boyle RA; Hewitt PM; Morris DL, 2001, 'lipiodol avidity of Hepatic Breast carcinoma metastases', Anticancer Research, pp. 3725 - 3728

Morris DL; Jourdan J; Pourgholami MH, 2001, 'Pilot study of albendazole in patients with advanced malignancy', Oncology, pp. 42 - 46

Gruenberger T; Jourdan J; Zhao J; King J; Morris DL, 2001, 'Reduction in Recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases', Arzneimittel - Forschung - Drug Research, 136, pp. 1154 - 1157

Harrison JD; Steele RJ; Morris DL; Hardcastle JD, 2001, 'Screening for gastric cancer: Endoscopic investigation of dyspeptic subjects identified by postal questionnaire', GI Cancer An International Journal, pp. 335 - 342

Ho C; Shumack SP; Morris DL, 2001, 'Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma', Australasian Journal of Dermatology, pp. 110 - 113

Butler P; Morris DL; King J; Mckay E; Parkes SL; Ring MT, 2001, 'Survival in patients with hepatocellular carcinoma treated with intra-arterial I-131 labelled lipiodol', GI Cancer An International Journal, pp. 359 - 369

King J; Gebski V; Morris DL, 2000, 'Relationship between quality of life (QoL) and a biological marker of outcome in patients with liver cancer.', PSYCHO-ONCOLOGY, 9, pp. S57 - S57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089846700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Filice C; Brunetti E; Bruno R; Crippa FG; Vuitton D; Schantz P; Caremani M; Giorgio A; Bastid C; Stefaniak J; Zeyhle E; Wen H; Pelaez V; Pettinari R; Akhan O; Men S; Hernandez G; Schipper H; Morris DL, 2000, 'Percutaneous drainage of echinococcal cysts (PAIR - puncture, aspiration, injection, reaspiration): Results of a worldwide survey for assessment of its safety and efficacy [7] (multiple letters)', Gut, 47, pp. 156 - 157, http://dx.doi.org/10.1136/gut.47.1.156

Morris DL, 2000, 'Percutaneous drainage of echinococcal cysts (PAIR-puncture, aspiration, injection, reaspiration): results of a worldwide survey for assessment of its safety end efficacy - Reply', GUT, 47, pp. 157 - 157, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000087935500038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL, 2000, 'Lipid delivery agents for 1,25-dihydroxyvitamin D3 administration - A new treatment for hepatoma?', GUT, 46, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086170200287&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Finlay IG; Seifert JK; Stewart GJ; Morris DL, 2000, 'Erratum: Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone (European Journal of Surgical Oncology (2000) 26:3 (199-202))', European Journal of Surgical Oncology, 26, pp. 524 - 525, http://dx.doi.org/10.1053/ejso.2000.0939

Morris DL, 2000, 'Symposium on unresectable or advanced liver cancer', Asian Journal of Surgery, 23, pp. 1 - 2, http://dx.doi.org/10.1007/s101160050001

Pourgholami MH; Akhter J; Finlay I; Morris DL, 2000, '1,25 dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferate effect in the human hepatoblastoma cell line hepG2.', Anticancer Research, 20, pp. 723 - 728

Bagia S; Hewitt PM; Morris DL, 2000, 'Anabolic steroid-induced hapatic adenomas with spontaneous haemorrhage in a bodybuider.', Australian and New Zealand Journal of Surgery, pp. 686 - 687

Johnston MB; Gal M; Lobo C; Perret N; Morris DL; Zou J; Cockayne DJ; Leon R, 2000, 'Carrier capture and relaxation in Stranski-Krastanow InxGa1-xAs/GaAs(311)B quantum dots', Physical Review - Section B - Condensed Matter, pp. 2737 - 2742

Jourdan J; Morris DL, 2000, 'Cryotherapy for unresectable liver cancers.', Asian Journal of Surgery, pp. 16 - 21

Gruenberger T; Jourdan J; Zhao J; King J; Morris DL, 2000, 'Echogenicity of liver metastases is an independent prognostic factor after curative treatment.', Archives of Surgery, 135, pp. 1285 - 1290

North H; King J; Morris DL, 2000, 'Effect of Marimastat on serum tumour markers in patients with colorectal cancer.', International Journal of Surgical Investigation, 2, pp. 213 - 217

Bolton E; King J; Morris DL, 2000, 'H2-antagonists in the treatment of colon and breast cancer.', Seminars in Cancer Biology, 10, pp. 3 - 10

Morris DL; Fox BJ; Luo J; Monamy V, 2000, 'Habitat-dependent competition and the co-existence of Australian heathland rodents', Oikos, pp. 294 - 306

Jourdan J; Akhter J; Bowrey P; Pourgholami MH; Morris DL, 2000, 'Hepatic intra-arterial injection of lipiodol- 1,25-dihydroxyvitamine D3 for hepatcellular carcinoma in rats.', Anticancer Research, 20, pp. 2739 - 2744

Bowrey P; King J; Magarey CJ; Schwartz P; Marr PJ; Bolton E; Morris DL, 2000, 'Histamine, mast cells and tumour cell proloferation in breast cancer. Does preoperative cimetidine administration have an effect?', British Journal of Cancer, pp. 167 - 170

Pourgholami MH; Akhter J; Lu Y; Morris DL, 2000, 'In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.', Cancer Letters, 1, pp. 97 - 102

Pourgholami MH; Akhter J; Morris DL, 2000, 'In vitro antiproliferative activity of a medium-chain triglyceride solution of 1,25-dihydroxyvitamin D3 in hepG2 cells.', Anticancer Research, 20, pp. 4257 - 4260

Hewitt PM; Butler SP; Glenn DW; Morris DL, 2000, 'Lipiodol avidity and regression of hepatic metastases from nasopharyngeal carcinoma after regional radioiodine therapy: A case report.', Asian Journal of Surgery, pp. 181 - 183

Seifert JK; Morris DL, 2000, 'Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer.', International Journal of Surgical Investigation, 2, pp. 327 - 334

Valiozis I; Zekry A; Williams SJ; Hunt DR; Bourke MJ; Jorgensen J; Morris DL; Craig PA, 2000, 'Palliation of hilar obstruction from colorectal metastases by endoscopic stent insertion.', Gastrointestinal Endoscopy, pp. 412 - 417

Perera D; King J; Zhao J; Morris DL, 2000, 'Patients with hepatic metastases from colorectal cancer diagnosed by CEA or CT surveillance are more likely to have a potentially curable procedure than those with a symptomatic presentation.', GI Cancer An International Journal, pp. 189 - 192

Finlay I; Seifert JK; Stewart GJ; Morris DL, 2000, 'Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone.', European Journal of Surgical Oncology, pp. 199 - 202

Cheung D; Morris DL, 2000, 'Synchronous hepatic cryotherapy and resection of colonic primary is a high risk procedure.', HPB Surgery, 11, pp. 379 - 382

Ryan J, 2000, 'Thalidomide treatment of oesophageal ulceration.', Gut, 47, pp. 156, http://dx.doi.org/10.1136/gut.47.1.156

Finlay I; Stewart GA; Pourgholami MH; Akhter J; Morris DL, 2000, 'The use of lipiodol and medium cahin triglyceride as delivery agents for hepatic arterial administration of 1,25-dihydroxyvitamine D3 - A Potential new treatment for hepatoma.', Anticancer Research, 20, pp. 2705 - 2710

Oh CM; Morris DL, 1999, 'Perfusion of the oesophagus and stomach during hepatic artery chemotherapy via an aberrant gastric artery', Australasian Radiology, 43, pp. 119 - 120, http://dx.doi.org/10.1046/j.1440-1673.1999.00594.x

Seifert JK; Morris DL, 1999, 'A world survey on the complications of hepatic and prostate cryotherapy.', World Journal of Surgery, pp. 109 - 114

Chen X; Akhter J; Bolton E; Morris DL, 1999, 'Antiproliferative activity of the Vitamin D3 analogue EB1089 on human colon cancer cell lines correlates with expression of Vitamin D receptor mRNA. British Journal of Cancer', British Journal of Cancer

Dwerryhouse S; Soon L; King JA; Magarey CJ; Schwartz P; Morris DL, 1999, 'Cimetidine does not influence TIL in breast cancer.', International Journal of Surgical Investigation, 1, pp. 191 - 194

Seifert JK; Bolton E; Junginger T; Morris DL, 1999, 'Cytokine release following hepatic cryotherapy in a rat model', Langenbecks Archives of Surgery, pp. 57 - 60

Seifert JK; Morris DL, 1999, 'Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer.', British Journal of Surgery, pp. 234 - 240

Seifert JK; Morris DL, 1999, 'Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer.', British Journal of Surgery, pp. 234 - 240

Seifert JK; Stewart GJ; Hewitt PM; Bolton E; Junginger T; Morris DL, 1999, 'Interleukin-6 and Tumour Necrosis Factor-alpha levels following hepatic cryotherapy are associated with volume and duration of freezing.', World Journal of Surgery, pp. 1019 - 1026

Back to profile page